Acute kidney injury (AKI) is a common and serious process that occurs in a wide variety of clinical settings. Lack of early AKI biomarkers has impeded timely interventions to ameliorate the downstream effects of AKI and has hindered further clinical investigation of therapies that are effective in animal studies

Download Document

« Back